 CARLSBAD, Calif., May 20, 2022 GLOBE NEWSWIRE -- Qualigen Therapeutics, Inc. Nasdaq: QLGN, a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces that Qualigen Therapeutics Management will present a corporate overview during the H.C. Wainwright Global Investment Conference. The conference is being held on May 23 26, 2022 at the Fontainebleau Hotel in Miami Beach, FL and virtually. 